DISCLAIMER — Not financial advice. Educational content only, not an offer or solicitation to buy or sell any security. Biotech and small/mid-cap stocks are highly speculative and volatile and can result in a partial or total loss of capital. Do your own research and consult a licensed advisor where appropriate.
Read Disclaimer

Category TENX

Tenax Therapeutics Inc

TENX Tenax Therapeutics Inc

Tenax Therapeutics (TENX) – Deep Dive / Analisi Approfondita (Jan 2023 – Oggi) Tenax Therapeutics (TENX) – Deep Dive / Analisi Approfondita (Jan 2023 – Oggi) Full deep dive on TENX: financials, pipeline, catalysts, shareholder structure, insider activity, dilution, analyst…

TENX Tenax Therapeutics

TENX

Tenax Therapeutics is advancing oral levosimendan for pulmonary hypertension associated with HFpEF (PH-HFpEF), with a registrational path built around the LEVEL Phase 3 program and a planned second global Phase 3 study (LEVEL-2) accepted by FDA in 2025.

$TENX

Tendenze di trading e analisi tecnica con Grafici di Tension, Tena, Therapeutics Inc.

Segnalata da Lazy del Fol., questa si è “risvegliata” già un mese fà… i volumi lo mostrano(oltre al prezzo). Ha un float bassisimo (circa 6M) percui si muove con poco. Catalyst vicini importantissimi non ne vedo, salvo la possibile approvazione…